Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series
Emmanuel Dudoignon, François Caméléna, Benjamin Deniau, Adrien Habay, Maxime Coutrot, Quentin Ressaire, Benoît Plaud, Béatrice Berçot, François Dépret
Abstract
72 (1 March) 905 molecular test named FilmArray Pneumonia plus panel (BioFire, Salt Lake City, Utah) showed excellent performance compared to bacterial culture in bacterial pneumonia with rapid turnaround time [6]. This new tool for detection of pathogens could lead to a reduction of spectrum and duration of antibiotic therapy.
Topics & Concepts
PneumoniaCoronavirus disease 2019 (COVID-19)Critically illSeries (stratigraphy)2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineVirologyBiologyInternal medicineOutbreakInfectious disease (medical specialty)PaleontologyDiseaseNosocomial Infections in ICUAntibiotic Use and ResistancePneumonia and Respiratory Infections